4basebio (XTER:88Q) FFO


XTER:88Q 4basebio PLC XTER:88Q
64 GF Score
Price €5.90
GF Value €34.35
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is 4basebio FFO?

FFO (Funds from operations) only applies to REITs.

XTER:88Q
64GF Score
4basebio PLC XTER:88Q
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 4basebio (XTER:88Q) Overvalued in 2026?

Based on GuruFocus' analysis, 4basebio stock appears to be undervalued. The current stock price of €5.90 is trading 82.8% below its estimated GF Value™ of €34.35. GuruFocus considers 4basebio to be Possible Value Trap.

Key valuation signals for XTER:88Q:

  • FFO:
  • GF Value™: €34.35 vs. price of €5.90 (82.8% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the XTER:88Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


4basebio Business Description

Other Exchanges 4BB:UK
Address 25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.
64GF Score

Get the complete analysis for XTER:88Q

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.90
Price
€34.35
GF Value